REAUTHORIZATION; REPORTING REQUIREMENTS.

SEC. 2004. REAUTHORIZATION; REPORTING REQUIREMENTS. (a) Performance Reports.—Section 738A(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-1(a)) is amended— (1) by striking “fiscal year 2018” each place it appears and inserting “fiscal year 2023”; (2) by striking “Medical Device User Fee Amendments of 2017” each place it appears and inserting “Medical Device User Fee Amendments of 2022”; (3) in paragraph (1)— (A) in subparagraph (A), by redesignating the second clause (iv) (relating to analysis) as clause (v); and (B) in subparagraph (A)(iv), by striking “fiscal year 2020” and inserting “fiscal year 2023”; and (4) in paragraph (4), by striking “2018 through 2022” and inserting “2023 through 2027”. (b) Reauthorization.—Section 738A(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-1(b)) is amended— (1) in paragraph (1), by striking “2022” and inserting “2027”; and (2) in paragraph (5), by striking “2022” and inserting “2027”.